Kidney Disease Clinical Trials

Showing 1721-1740 of 1,850 trials

Vitamin D Metabolism in Chronic Kidney Disease Patients

NCT01528176

To determine whether or not chronic kidney disease (CKD), stages III-V and ESRD , is associated with altered vitamin D metabolism related to fibroblast growth factor-23 (FGF-23) stimulation of Cyp24 and whether they have resistance to elevations of 25 Hydroxyvitamin D (25(OH)D3) after cholecalciferol supplementation. To determine if such resistance is related to enhanced catabolism of (25(OH)related to elevated levels of FGF-23.

Vitamin D Metabolism is in Chronic Kidney Disease

Memphis VA Medical Center70 participantsStarted Nov 2010

Memphis, Tennessee, United States

UNKNOWNPhase 2

Resection of Pulmonary Metastasis in Clear Cell Renal Cell Carcinoma +/-Adjuvant Sunitinib Therapy (SMAT)

NCT01216371

The aim ist to identify biomarkers in the blood, to indicate early response or early treatment resistance.

Renal Cell CarcinomaPulmonary Metastases

Association of Urologic Oncology (AUO)60 participantsStarted Oct 2010

Berlin, Germany • Berlin, Germany • Berlin, Germany +8 more locations

Vitamin D Metabolism in Chronic Kidney Disease Patients

Resection of Pulmonary Metastasis in Clear Cell Renal Cell Carcinoma +/-Adjuvant Sunitinib Therapy (SMAT)

Related Searches

Aldosterone Blockade in Chronic Kidney Disease: Influence on Arterial Stiffness and Kidney Function

Renal Safety of Iopamidol Versus Iodixanol During Coronary Angiography in Diabetic Patients

Initial Dosage Range of Tacrolimus by Genotyping in Chinese Renal Transplantation

Adrenalectomy for Solitary Adrenal Gland Metastases

Safety, Tolerability and Efficacy of Everolimus With Lower Versus Higher Levels of Tacrolimus in de Novo Renal Transplant Patients

This is a Two-year Follow-up Study to Evaluate the Long-term Safety, Tolerability and Efficacy of 2 Different Doses of Everolimus

Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial Dose

A Research Proposal to Set up an Integrated National Data Bank and Monitoring System and to Establish the Indicators and Risk Factors for Chronic Kidney Disease

Comparison of Soy-milk and Cow Milk Consumption on Inflammatory Factors, Cardiovascular Factors ,Renal Factors, Fibrinolytic Indice and Oxidative Stress Among Type-2 Diabetic Patients With Nephropathy Stage 1 and 2

Adrenal Suppression and Adrenal Recovery Induced by Megestrol Acetate

Vitamin K2 Supplementation to Activate Matrix Gla Protein (MGP) as Endogenous Inhibitor of Vascular Calcification in Hemodialysis Patients

Sevelamer, FGF-23 and Endothelial Dysfunction in Chronic Kidney Disease (CKD)

Salivary Phosphorus and Level of Kidney Function

Effects of High Cut-off (HCO) Hemodialysis on Central Memory CD4+ T and Treg Cells in Patients With End-stage Kidney Disease

Characterization of Immunological Profile of Renal Transplant Patients Undergoing Induction Treatment With Thymoglobulin vs. IL-2 Receptor Antagonist Basiliximab

A Study of Fostamatinib in Subjects With Impaired Kidney Function

Serum Magnesium and Vascular Calcification

A Dose Conversion Study of Epoetin Alfa in Subjects With the Anemia of Chronic Kidney Disease.